F. Bernardi et al., MOLECULAR DEFECTS IN CRM-VII DEFICIENCIES - MODELING OF MISSENSE MUTATIONS IN THE CATALYTIC DOMAIN OF FVII( FACTOR), British Journal of Haematology, 86(3), 1994, pp. 610-618
The molecular defects causing CRM+ factor VII deficiency were investig
ated in seven unrelated subjects and several members of their families
. Four missense mutations located in the catalytic domain of factor VI
I were found. The previously reported (304)Arg-->Gln substitution was
present in the homozygous and heterozygous forms, with different polym
orphic haplotypes, thus demonstrating that it is recurrent and frequen
t in the Italian population. The (310)Cys-->Phe substitution was found
in the homozygous form and in the compound heterozygous condition wit
h the nonsense mutation (356)Trp-->stop. Two missense mutations, (298)
Met-->Ile and (342)Gly-->Arg, were found in the homozygous and in the
heterozygous condition respectively. Molecular heterogeneity was furth
er increased by finding of the (353)Arp-->Gln polymorphism in the doub
ly heterozygous condition with the 304 and 342 mutations. Plausible ex
planations for loss of FVII function were found by inspecting a model
of the serine protease domain of factor VIIa. Inefficient activation o
f the catalytic site is predicted for (298)Met-->Ile. (342)Gly-->Arg w
ould directly distort the geometry of the 'oxyanion hole' preventing f
ormation of a substrate enzyme intermediate. (310)Cys-->Phe is predict
ed to have an adverse effect on tissue factor interaction. These mutat
ions point to important regions of the factor VII molecule.